Association between retinal thickness and β-amyloid brain accumulation in individuals with subjective cognitive decline: Fundació ACE Healthy Brain Initiative
Background Optical coherence tomography (OCT) of the retina is a fast and easily accessible tool for the quantification of retinal structural measurements. Multiple studies show that patients with Alzheimer’s disease (AD) exhibit thinning in several retinal layers compared to age-matched controls. S...
Saved in:
Published in | Alzheimer's research & therapy Vol. 12; no. 1; pp. 37 - 14 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central
31.03.2020
BMC |
Subjects | |
Online Access | Get full text |
ISSN | 1758-9193 1758-9193 |
DOI | 10.1186/s13195-020-00602-9 |
Cover
Abstract | Background
Optical coherence tomography (OCT) of the retina is a fast and easily accessible tool for the quantification of retinal structural measurements. Multiple studies show that patients with Alzheimer’s disease (AD) exhibit thinning in several retinal layers compared to age-matched controls. Subjective cognitive decline (SCD) has been proposed as a risk factor for progression to AD. There is little data about retinal changes in preclinical AD and their correlation with amyloid-β (Aβ) uptake.
Aims
We investigated the association of retinal thickness quantified by OCT with Aβ accumulation and conversion to mild cognitive impairment (MCI) over 24 months in individuals with SCD.
Methods
One hundred twenty-nine individuals with SCD enrolled in Fundació ACE Healthy Brain Initiative underwent comprehensive neuropsychological testing, OCT scan of the retina and florbetaben (FBB) positron emission tomography (PET) at baseline (v0) and after 24 months (v2). We assessed the association of sixteen retinal thickness measurements at baseline with FBB-PET status (+/−) and global standardize uptake value ratio (SUVR) as a continuous measure at v0 and v2 and their predictive value on clinical status change (conversion to mild cognitive impairment (MCI)) at v2.
Results
Mean age of the sample was 64.72 ± 7.27 years; 62.8% were females. Fifteen participants were classified as FBB-PET+ at baseline and 22 at v2. Every 1 μm of increased thickness in the inner nasal macular region conferred 8% and 6% higher probability of presenting a FBB-PET+ status at v0 (OR = 1.08, 95% CI = 1.02–1.14,
p
= 0.007) and v2 (OR = 1.06, 95% CI = 1.02–1.11,
p
= 0.004), respectively. Inner nasal macular thickness also positively correlated with global SUVR (at v0:
β
= 0.23,
p
= 0.004; at v2:
β
= 0.26,
p
= 0.001). No retinal measurements were associated to conversion to MCI over 24 months.
Conclusions
Subtle retinal thickness changes in the macular region are already present in SCD and correlate with Aβ uptake. |
---|---|
AbstractList | Abstract Background Optical coherence tomography (OCT) of the retina is a fast and easily accessible tool for the quantification of retinal structural measurements. Multiple studies show that patients with Alzheimer’s disease (AD) exhibit thinning in several retinal layers compared to age-matched controls. Subjective cognitive decline (SCD) has been proposed as a risk factor for progression to AD. There is little data about retinal changes in preclinical AD and their correlation with amyloid-β (Aβ) uptake. Aims We investigated the association of retinal thickness quantified by OCT with Aβ accumulation and conversion to mild cognitive impairment (MCI) over 24 months in individuals with SCD. Methods One hundred twenty-nine individuals with SCD enrolled in Fundació ACE Healthy Brain Initiative underwent comprehensive neuropsychological testing, OCT scan of the retina and florbetaben (FBB) positron emission tomography (PET) at baseline (v0) and after 24 months (v2). We assessed the association of sixteen retinal thickness measurements at baseline with FBB-PET status (+/−) and global standardize uptake value ratio (SUVR) as a continuous measure at v0 and v2 and their predictive value on clinical status change (conversion to mild cognitive impairment (MCI)) at v2. Results Mean age of the sample was 64.72 ± 7.27 years; 62.8% were females. Fifteen participants were classified as FBB-PET+ at baseline and 22 at v2. Every 1 μm of increased thickness in the inner nasal macular region conferred 8% and 6% higher probability of presenting a FBB-PET+ status at v0 (OR = 1.08, 95% CI = 1.02–1.14, p = 0.007) and v2 (OR = 1.06, 95% CI = 1.02–1.11, p = 0.004), respectively. Inner nasal macular thickness also positively correlated with global SUVR (at v0: β = 0.23, p = 0.004; at v2: β = 0.26, p = 0.001). No retinal measurements were associated to conversion to MCI over 24 months. Conclusions Subtle retinal thickness changes in the macular region are already present in SCD and correlate with Aβ uptake. Optical coherence tomography (OCT) of the retina is a fast and easily accessible tool for the quantification of retinal structural measurements. Multiple studies show that patients with Alzheimer's disease (AD) exhibit thinning in several retinal layers compared to age-matched controls. Subjective cognitive decline (SCD) has been proposed as a risk factor for progression to AD. There is little data about retinal changes in preclinical AD and their correlation with amyloid-β (Aβ) uptake.BACKGROUNDOptical coherence tomography (OCT) of the retina is a fast and easily accessible tool for the quantification of retinal structural measurements. Multiple studies show that patients with Alzheimer's disease (AD) exhibit thinning in several retinal layers compared to age-matched controls. Subjective cognitive decline (SCD) has been proposed as a risk factor for progression to AD. There is little data about retinal changes in preclinical AD and their correlation with amyloid-β (Aβ) uptake.We investigated the association of retinal thickness quantified by OCT with Aβ accumulation and conversion to mild cognitive impairment (MCI) over 24 months in individuals with SCD.AIMSWe investigated the association of retinal thickness quantified by OCT with Aβ accumulation and conversion to mild cognitive impairment (MCI) over 24 months in individuals with SCD.One hundred twenty-nine individuals with SCD enrolled in Fundació ACE Healthy Brain Initiative underwent comprehensive neuropsychological testing, OCT scan of the retina and florbetaben (FBB) positron emission tomography (PET) at baseline (v0) and after 24 months (v2). We assessed the association of sixteen retinal thickness measurements at baseline with FBB-PET status (+/-) and global standardize uptake value ratio (SUVR) as a continuous measure at v0 and v2 and their predictive value on clinical status change (conversion to mild cognitive impairment (MCI)) at v2.METHODSOne hundred twenty-nine individuals with SCD enrolled in Fundació ACE Healthy Brain Initiative underwent comprehensive neuropsychological testing, OCT scan of the retina and florbetaben (FBB) positron emission tomography (PET) at baseline (v0) and after 24 months (v2). We assessed the association of sixteen retinal thickness measurements at baseline with FBB-PET status (+/-) and global standardize uptake value ratio (SUVR) as a continuous measure at v0 and v2 and their predictive value on clinical status change (conversion to mild cognitive impairment (MCI)) at v2.Mean age of the sample was 64.72 ± 7.27 years; 62.8% were females. Fifteen participants were classified as FBB-PET+ at baseline and 22 at v2. Every 1 μm of increased thickness in the inner nasal macular region conferred 8% and 6% higher probability of presenting a FBB-PET+ status at v0 (OR = 1.08, 95% CI = 1.02-1.14, p = 0.007) and v2 (OR = 1.06, 95% CI = 1.02-1.11, p = 0.004), respectively. Inner nasal macular thickness also positively correlated with global SUVR (at v0: β = 0.23, p = 0.004; at v2: β = 0.26, p = 0.001). No retinal measurements were associated to conversion to MCI over 24 months.RESULTSMean age of the sample was 64.72 ± 7.27 years; 62.8% were females. Fifteen participants were classified as FBB-PET+ at baseline and 22 at v2. Every 1 μm of increased thickness in the inner nasal macular region conferred 8% and 6% higher probability of presenting a FBB-PET+ status at v0 (OR = 1.08, 95% CI = 1.02-1.14, p = 0.007) and v2 (OR = 1.06, 95% CI = 1.02-1.11, p = 0.004), respectively. Inner nasal macular thickness also positively correlated with global SUVR (at v0: β = 0.23, p = 0.004; at v2: β = 0.26, p = 0.001). No retinal measurements were associated to conversion to MCI over 24 months.Subtle retinal thickness changes in the macular region are already present in SCD and correlate with Aβ uptake.CONCLUSIONSSubtle retinal thickness changes in the macular region are already present in SCD and correlate with Aβ uptake. Optical coherence tomography (OCT) of the retina is a fast and easily accessible tool for the quantification of retinal structural measurements. Multiple studies show that patients with Alzheimer's disease (AD) exhibit thinning in several retinal layers compared to age-matched controls. Subjective cognitive decline (SCD) has been proposed as a risk factor for progression to AD. There is little data about retinal changes in preclinical AD and their correlation with amyloid-β (Aβ) uptake. We investigated the association of retinal thickness quantified by OCT with Aβ accumulation and conversion to mild cognitive impairment (MCI) over 24 months in individuals with SCD. One hundred twenty-nine individuals with SCD enrolled in Fundació ACE Healthy Brain Initiative underwent comprehensive neuropsychological testing, OCT scan of the retina and florbetaben (FBB) positron emission tomography (PET) at baseline (v0) and after 24 months (v2). We assessed the association of sixteen retinal thickness measurements at baseline with FBB-PET status (+/-) and global standardize uptake value ratio (SUVR) as a continuous measure at v0 and v2 and their predictive value on clinical status change (conversion to mild cognitive impairment (MCI)) at v2. Mean age of the sample was 64.72 ± 7.27 years; 62.8% were females. Fifteen participants were classified as FBB-PET+ at baseline and 22 at v2. Every 1 μm of increased thickness in the inner nasal macular region conferred 8% and 6% higher probability of presenting a FBB-PET+ status at v0 (OR = 1.08, 95% CI = 1.02-1.14, p = 0.007) and v2 (OR = 1.06, 95% CI = 1.02-1.11, p = 0.004), respectively. Inner nasal macular thickness also positively correlated with global SUVR (at v0: β = 0.23, p = 0.004; at v2: β = 0.26, p = 0.001). No retinal measurements were associated to conversion to MCI over 24 months. Subtle retinal thickness changes in the macular region are already present in SCD and correlate with Aβ uptake. Background Optical coherence tomography (OCT) of the retina is a fast and easily accessible tool for the quantification of retinal structural measurements. Multiple studies show that patients with Alzheimer’s disease (AD) exhibit thinning in several retinal layers compared to age-matched controls. Subjective cognitive decline (SCD) has been proposed as a risk factor for progression to AD. There is little data about retinal changes in preclinical AD and their correlation with amyloid-β (Aβ) uptake. Aims We investigated the association of retinal thickness quantified by OCT with Aβ accumulation and conversion to mild cognitive impairment (MCI) over 24 months in individuals with SCD. Methods One hundred twenty-nine individuals with SCD enrolled in Fundació ACE Healthy Brain Initiative underwent comprehensive neuropsychological testing, OCT scan of the retina and florbetaben (FBB) positron emission tomography (PET) at baseline (v0) and after 24 months (v2). We assessed the association of sixteen retinal thickness measurements at baseline with FBB-PET status (+/−) and global standardize uptake value ratio (SUVR) as a continuous measure at v0 and v2 and their predictive value on clinical status change (conversion to mild cognitive impairment (MCI)) at v2. Results Mean age of the sample was 64.72 ± 7.27 years; 62.8% were females. Fifteen participants were classified as FBB-PET+ at baseline and 22 at v2. Every 1 μm of increased thickness in the inner nasal macular region conferred 8% and 6% higher probability of presenting a FBB-PET+ status at v0 (OR = 1.08, 95% CI = 1.02–1.14, p = 0.007) and v2 (OR = 1.06, 95% CI = 1.02–1.11, p = 0.004), respectively. Inner nasal macular thickness also positively correlated with global SUVR (at v0: β = 0.23, p = 0.004; at v2: β = 0.26, p = 0.001). No retinal measurements were associated to conversion to MCI over 24 months. Conclusions Subtle retinal thickness changes in the macular region are already present in SCD and correlate with Aβ uptake. Background Optical coherence tomography (OCT) of the retina is a fast and easily accessible tool for the quantification of retinal structural measurements. Multiple studies show that patients with Alzheimer’s disease (AD) exhibit thinning in several retinal layers compared to age-matched controls. Subjective cognitive decline (SCD) has been proposed as a risk factor for progression to AD. There is little data about retinal changes in preclinical AD and their correlation with amyloid-β (Aβ) uptake. Aims We investigated the association of retinal thickness quantified by OCT with Aβ accumulation and conversion to mild cognitive impairment (MCI) over 24 months in individuals with SCD. Methods One hundred twenty-nine individuals with SCD enrolled in Fundació ACE Healthy Brain Initiative underwent comprehensive neuropsychological testing, OCT scan of the retina and florbetaben (FBB) positron emission tomography (PET) at baseline (v0) and after 24 months (v2). We assessed the association of sixteen retinal thickness measurements at baseline with FBB-PET status (+/−) and global standardize uptake value ratio (SUVR) as a continuous measure at v0 and v2 and their predictive value on clinical status change (conversion to mild cognitive impairment (MCI)) at v2. Results Mean age of the sample was 64.72 ± 7.27 years; 62.8% were females. Fifteen participants were classified as FBB-PET+ at baseline and 22 at v2. Every 1 μm of increased thickness in the inner nasal macular region conferred 8% and 6% higher probability of presenting a FBB-PET+ status at v0 (OR = 1.08, 95% CI = 1.02–1.14, p = 0.007) and v2 (OR = 1.06, 95% CI = 1.02–1.11, p = 0.004), respectively. Inner nasal macular thickness also positively correlated with global SUVR (at v0: β = 0.23, p = 0.004; at v2: β = 0.26, p = 0.001). No retinal measurements were associated to conversion to MCI over 24 months. Conclusions Subtle retinal thickness changes in the macular region are already present in SCD and correlate with Aβ uptake. |
ArticleNumber | 37 |
Author | Pavia, Javier Ortega, Gemma Tejero, Miguel Ángel Alegret, Montserrat Rosende-Roca, Maitee Gómez-Chiari, Marta Ciudin, Andreea Benaque, Alba Sanabria, Ángela Boada, Mercè Roberto, Natalia Simó, Rafael Ruiz, Agustín Martínez, Joan Hernández, Isabel Orellana, Adelina Mauleón, Ana Vargas, Liliana Valero, Sergi Marquié, Marta Monté-Rubio, Gemma C. Montrreal, Laura Castilla-Marti, Miguel Hernández, Cristina Tárraga, Lluís Vivas, Assumpta Tartari, Juan Pablo Sotolongo-Grau, Oscar Esteban-De Antonio, Ester Rodríguez-Gómez, Octavio Espinosa, Ana Abdelnour, Carla de Rojas, Itziar Lomeña, Francisco Moreno-Grau, Sonia Gil, Silvia Pérez-Cordón, Alba |
Author_xml | – sequence: 1 givenname: Marta surname: Marquié fullname: Marquié, Marta email: mmarquie@fundacioace.org organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC), Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III – sequence: 2 givenname: Sergi surname: Valero fullname: Valero, Sergi organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC), Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III – sequence: 3 givenname: Miguel surname: Castilla-Marti fullname: Castilla-Marti, Miguel organization: Clínica Oftalmológica Dr. Castilla, Department of Ophthalmology, Hospital del Mar and Hospital de l’Esperança - Parc de Salut Mar – sequence: 4 givenname: Joan surname: Martínez fullname: Martínez, Joan organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC) – sequence: 5 givenname: Octavio surname: Rodríguez-Gómez fullname: Rodríguez-Gómez, Octavio organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC) – sequence: 6 givenname: Ángela surname: Sanabria fullname: Sanabria, Ángela organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC), Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III – sequence: 7 givenname: Juan Pablo surname: Tartari fullname: Tartari, Juan Pablo organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC) – sequence: 8 givenname: Gemma C. surname: Monté-Rubio fullname: Monté-Rubio, Gemma C. organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC), Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III – sequence: 9 givenname: Oscar surname: Sotolongo-Grau fullname: Sotolongo-Grau, Oscar organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC) – sequence: 10 givenname: Montserrat surname: Alegret fullname: Alegret, Montserrat organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC), Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III – sequence: 11 givenname: Alba surname: Pérez-Cordón fullname: Pérez-Cordón, Alba organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC) – sequence: 12 givenname: Natalia surname: Roberto fullname: Roberto, Natalia organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC) – sequence: 13 givenname: Itziar surname: de Rojas fullname: de Rojas, Itziar organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC) – sequence: 14 givenname: Sonia surname: Moreno-Grau fullname: Moreno-Grau, Sonia organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC), Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III – sequence: 15 givenname: Laura surname: Montrreal fullname: Montrreal, Laura organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC) – sequence: 16 givenname: Isabel surname: Hernández fullname: Hernández, Isabel organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC), Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III – sequence: 17 givenname: Maitee surname: Rosende-Roca fullname: Rosende-Roca, Maitee organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC) – sequence: 18 givenname: Ana surname: Mauleón fullname: Mauleón, Ana organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC) – sequence: 19 givenname: Liliana surname: Vargas fullname: Vargas, Liliana organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC) – sequence: 20 givenname: Carla surname: Abdelnour fullname: Abdelnour, Carla organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC) – sequence: 21 givenname: Silvia surname: Gil fullname: Gil, Silvia organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC), Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III – sequence: 22 givenname: Ester surname: Esteban-De Antonio fullname: Esteban-De Antonio, Ester organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC) – sequence: 23 givenname: Ana surname: Espinosa fullname: Espinosa, Ana organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC), Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III – sequence: 24 givenname: Gemma surname: Ortega fullname: Ortega, Gemma organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC), Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III – sequence: 25 givenname: Francisco surname: Lomeña fullname: Lomeña, Francisco organization: Department of Radiology, Hospital Clínic i Provincial de Barcelona, Universitat de Barcelona – sequence: 26 givenname: Javier surname: Pavia fullname: Pavia, Javier organization: Department of Radiology, Hospital Clínic i Provincial de Barcelona, Universitat de Barcelona – sequence: 27 givenname: Assumpta surname: Vivas fullname: Vivas, Assumpta organization: Department of Diagnostic Imaging, Clínica Corachan – sequence: 28 givenname: Miguel Ángel surname: Tejero fullname: Tejero, Miguel Ángel organization: Department of Diagnostic Imaging, Clínica Corachan – sequence: 29 givenname: Marta surname: Gómez-Chiari fullname: Gómez-Chiari, Marta organization: Department of Diagnostic Imaging, Clínica Corachan – sequence: 30 givenname: Rafael surname: Simó fullname: Simó, Rafael organization: Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Institut de Recerca Vall d’Hebron, Universitat Autònoma de Barcelona (VHIR-UAB) – sequence: 31 givenname: Andreea surname: Ciudin fullname: Ciudin, Andreea organization: Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Institut de Recerca Vall d’Hebron, Universitat Autònoma de Barcelona (VHIR-UAB) – sequence: 32 givenname: Cristina surname: Hernández fullname: Hernández, Cristina organization: Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Institut de Recerca Vall d’Hebron, Universitat Autònoma de Barcelona (VHIR-UAB) – sequence: 33 givenname: Adelina surname: Orellana fullname: Orellana, Adelina organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC), Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III – sequence: 34 givenname: Alba surname: Benaque fullname: Benaque, Alba organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC) – sequence: 35 givenname: Agustín surname: Ruiz fullname: Ruiz, Agustín organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC), Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III – sequence: 36 givenname: Lluís surname: Tárraga fullname: Tárraga, Lluís organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC), Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III – sequence: 37 givenname: Mercè surname: Boada fullname: Boada, Mercè organization: Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC), Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32234080$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kstu1DAUhiNURC_wAiyQJTZsAr7lYhZIQ9XSkSqx6d5y7JMZDxm72M5U8zY8AzwCe54JZ6aUtotKkXLkfP_vc07-4-LAeQdF8Zrg94S09YdIGBFViSkuMa4xLcWz4og0VVsKItjBvfqwOI5xlaGatvxFccgoZRy3-Kj4MYvRa6uS9Q51kG4AHAqQrFMDSkurvzmIESln0J-fpVpvB28N6oKyDimtx_U47LV2eozdWDOqIaIbm5Yojt0KdLIbQNovnN1VBvRgHXxE56MzStvfv9Ds9AxdgBrScos-76znE6wm_mXxvM-G8Or2fVJcnZ9dnV6Ul1-_zE9nl6WuOE55Sk4I7lXVNryvuaLC1H2lOwxQa821AdEK0jei64ShQrBO5AVwWgHLaxHspJjvbY1XK3kd7FqFrfTKyt2BDwupQrJ6ANlogxvSMdbinhvaKtPXjHdVp3poqx6y16e91_XYrcFocCmo4YHpwy_OLuXCb2STR2gYzgbvbg2C_z5CTHJto4ZhUA78GCVlbdVQXokmo28foSs_hvzzJiovpSGCk0y9ud_RXSv_cpABugd08DEG6O8QguUUNrkPm8xhk7uwyWln7SORtmmXhjyVHZ6Wsr005nvcAsL_tp9Q_QUede1q |
CitedBy_id | crossref_primary_10_3390_ijms23052486 crossref_primary_10_1136_bmjopen_2023_072626 crossref_primary_10_3389_fneur_2022_1014359 crossref_primary_10_1016_j_snb_2024_135364 crossref_primary_10_14283_jpad_2023_118 crossref_primary_10_1136_bmjopen_2021_054657 crossref_primary_10_1111_jcmm_18495 crossref_primary_10_1111_cns_14525 crossref_primary_10_1002_dad2_12275 crossref_primary_10_3389_fnins_2023_1076177 crossref_primary_10_1038_s41598_022_21558_w crossref_primary_10_4103_1673_5374_371380 crossref_primary_10_3390_biomedicines11072024 crossref_primary_10_2147_EB_S235238 crossref_primary_10_1186_s13195_024_01616_3 crossref_primary_10_1016_j_preteyeres_2020_100938 crossref_primary_10_1167_tvst_13_2_16 crossref_primary_10_3233_JAD_220596 crossref_primary_10_1007_s11011_022_00927_4 crossref_primary_10_1016_j_preteyeres_2024_101273 crossref_primary_10_1177_11206721211016311 crossref_primary_10_1186_s13195_025_01676_z crossref_primary_10_3233_JAD_200735 crossref_primary_10_1097_WNO_0000000000001673 crossref_primary_10_1002_acn3_52172 crossref_primary_10_1002_dad2_12421 crossref_primary_10_1186_s13195_024_01408_9 |
Cites_doi | 10.1038/s41598-018-34577-3 10.1111/aos.14121 10.1097/IJG.0b013e318133fb32 10.1212/WNL.0b013e318245d295 10.1016/j.jalz.2016.03.001 10.1371/journal.pone.0116802 10.3389/fnagi.2017.00214 10.1016/S0002-9394(03)00792-X 10.1016/j.jalz.2014.01.001 10.1007/s13311-016-0481-z 10.3233/JAD-160915 10.1002/wsbm.22 10.1016/j.dadm.2016.09.001 10.1016/S0161-6420(90)32621-0 10.1016/j.jalz.2018.10.003 10.1016/j.archger.2014.10.015 10.1001/jama.2015.4668 10.1001/jamaophthalmol.2018.3556 10.1212/WNL.0000000000000856 10.1371/journal.pone.0076436 10.1111/aos.12614 10.1038/mp.2017.146 10.1364/OE.18.021293 10.1016/0022-3956(75)90026-6 10.1080/13803395.2012.666230 10.1016/j.jalz.2011.10.007 10.1016/j.jalz.2013.03.006 10.1016/S1474-4422(14)70194-2 10.1016/j.jalz.2011.03.005 10.1097/IAE.0b013e3181dde71e 10.1001/jama.2015.4669 10.3233/JAD-150594 10.1016/S0028-3932(01)00055-0 10.1016/j.jalz.2009.10.002 10.1007/s00415-014-7374-z 10.1016/j.neuroimage.2010.06.020 10.1126/scitranslmed.3002609 10.1212/WNL.43.11.2412-a 10.1080/13803395.2011.630652 10.1038/s41598-019-45055-9 10.1038/eye.2015.94 10.1186/s13195-017-0239-9 10.1016/j.visres.2017.05.009 |
ContentType | Journal Article |
Contributor | Ibarria, M Nogales, A B Sarasa, M Martín, E Berthier, M Romero, J Lafuente, A Torres, M Guitart, M Preckler, S Pancho, A Campos, F Bullich, S Núñez, L Pesini, P Giménez, J Buendia, M Gailhajanet, A Páez, A Ruiz, S Pérez-Grijalba, V Aguilera, N Cuevas, C Cañabate, P Gismondi, R Moreno, M Pelejà, E |
Contributor_xml | – sequence: 1 givenname: N surname: Aguilera fullname: Aguilera, N – sequence: 2 givenname: M surname: Berthier fullname: Berthier, M – sequence: 3 givenname: M surname: Buendia fullname: Buendia, M – sequence: 4 givenname: S surname: Bullich fullname: Bullich, S – sequence: 5 givenname: F surname: Campos fullname: Campos, F – sequence: 6 givenname: P surname: Cañabate fullname: Cañabate, P – sequence: 7 givenname: C surname: Cuevas fullname: Cuevas, C – sequence: 8 givenname: A surname: Gailhajanet fullname: Gailhajanet, A – sequence: 9 givenname: J surname: Giménez fullname: Giménez, J – sequence: 10 givenname: R surname: Gismondi fullname: Gismondi, R – sequence: 11 givenname: M surname: Guitart fullname: Guitart, M – sequence: 12 givenname: M surname: Ibarria fullname: Ibarria, M – sequence: 13 givenname: A surname: Lafuente fullname: Lafuente, A – sequence: 14 givenname: E surname: Martín fullname: Martín, E – sequence: 15 givenname: M surname: Moreno fullname: Moreno, M – sequence: 16 givenname: A B surname: Nogales fullname: Nogales, A B – sequence: 17 givenname: L surname: Núñez fullname: Núñez, L – sequence: 18 givenname: A surname: Páez fullname: Páez, A – sequence: 19 givenname: A surname: Pancho fullname: Pancho, A – sequence: 20 givenname: E surname: Pelejà fullname: Pelejà, E – sequence: 21 givenname: V surname: Pérez-Grijalba fullname: Pérez-Grijalba, V – sequence: 22 givenname: P surname: Pesini fullname: Pesini, P – sequence: 23 givenname: S surname: Preckler fullname: Preckler, S – sequence: 24 givenname: J surname: Romero fullname: Romero, J – sequence: 25 givenname: S surname: Ruiz fullname: Ruiz, S – sequence: 26 givenname: M surname: Sarasa fullname: Sarasa, M – sequence: 27 givenname: M surname: Torres fullname: Torres, M |
Copyright | The Author(s) 2020 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2020 – notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
CorporateAuthor | on behalf of the FACEHBI study group FACEHBI study group |
CorporateAuthor_xml | – name: on behalf of the FACEHBI study group – name: FACEHBI study group |
DBID | C6C AAYXX CITATION NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s13195-020-00602-9 |
DatabaseName | Springer Nature OA Free Journals CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials - QC ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1758-9193 |
EndPage | 14 |
ExternalDocumentID | oai_doaj_org_article_7cd071b3380f4d28adf634b5bafe85fe PMC7110730 32234080 10_1186_s13195_020_00602_9 |
Genre | Journal Article |
GrantInformation_xml | – fundername: Araclon Biotech grantid: N/A – fundername: Laboratorio de análisis Echevarne grantid: N/A – fundername: Alkahest grantid: N/A – fundername: Grifols – fundername: Fundació ACE Institut Català de Neurociències Aplicades grantid: N/A – fundername: European Foundation for the Study of Diabetes - ESFS/Lilly Mental Health and Diabetes 2013 Programme – fundername: IrsiCaixa grantid: N/A – fundername: Life Molecular Imaging grantid: N/A – fundername: H2020 Marie Skłodowska-Curie Actions grantid: 796706 funderid: http://dx.doi.org/10.13039/100010665 – fundername: H2020 Marie Skłodowska-Curie Actions grantid: 796706 – fundername: ; – fundername: ; grantid: N/A – fundername: ; grantid: 796706 |
GroupedDBID | --- 0R~ 23M 2WC 53G 5VS 6J9 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML ABDBF ABUWG ACGFS ACIHN ACJQM ACUHS ADBBV ADUKV AEAQA AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIAM AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU DIK E3Z EBD EBLON EBS ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE HZ~ IAO IEA IHR IHW INH INR ITC KQ8 M1P M~E O5R O5S O9- OK1 P2P P6G PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ ROL RPM RSV SBL SOJ TR2 TUS UKHRP AAYXX ALIPV CITATION -56 -5G -BR 3V. ACRMQ ADINQ C24 NPM 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c540t-914110fa5874f64a29d6f5cb0ee6cc4cde9891f79bb9d2993b9408425e300693 |
IEDL.DBID | 7X7 |
ISSN | 1758-9193 |
IngestDate | Wed Aug 27 01:31:55 EDT 2025 Thu Aug 21 14:05:52 EDT 2025 Fri Sep 05 05:39:50 EDT 2025 Sun Sep 07 03:30:14 EDT 2025 Thu Jan 02 22:59:18 EST 2025 Thu Apr 24 22:59:04 EDT 2025 Tue Jul 01 02:38:49 EDT 2025 Sat Sep 06 07:34:49 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | β-Amyloid Florbetaben Subjective cognitive decline Optical coherence tomography Retinal thickness Positron emission tomography |
Language | English |
License | Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c540t-914110fa5874f64a29d6f5cb0ee6cc4cde9891f79bb9d2993b9408425e300693 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://www.proquest.com/docview/2391471941?pq-origsite=%requestingapplication% |
PMID | 32234080 |
PQID | 2391471941 |
PQPubID | 2040174 |
PageCount | 14 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_7cd071b3380f4d28adf634b5bafe85fe pubmedcentral_primary_oai_pubmedcentral_nih_gov_7110730 proquest_miscellaneous_2385724597 proquest_journals_2391471941 pubmed_primary_32234080 crossref_primary_10_1186_s13195_020_00602_9 crossref_citationtrail_10_1186_s13195_020_00602_9 springer_journals_10_1186_s13195_020_00602_9 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2020-03-31 |
PublicationDateYYYYMMDD | 2020-03-31 |
PublicationDate_xml | – month: 03 year: 2020 text: 2020-03-31 day: 31 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Alzheimer's research & therapy |
PublicationTitleAbbrev | Alz Res Therapy |
PublicationTitleAlternate | Alzheimers Res Ther |
PublicationYear | 2020 |
Publisher | BioMed Central BMC |
Publisher_xml | – name: BioMed Central – name: BMC |
References | 602_CR44 J den Haan (602_CR13) 2017; 6 602_CR40 602_CR48 602_CR47 602_CR46 CR Jack (602_CR38) 2014; 13 S Ogata (602_CR6) 2015; 60 M Marquié (602_CR42) 2019; 9 K Goozee (602_CR35) 2018; 23 KM Rodrigue (602_CR39) 2012; 78 602_CR10 602_CR51 B Reisberg (602_CR5) 2010; 6 M Koronyo-Hamaoui (602_CR18) 2011; 54 F Jessen (602_CR4) 2014; 10 C Lamirel (602_CR16) 2009; 6 M Alegret (602_CR25) 2015; 48 GM McKhann (602_CR1) 2011; 7 RJ Kryscio (602_CR7) 2014; 83 CY Santos (602_CR49) 2018; 10 M Díaz-Coránguez (602_CR14) 2017; 139 WJ Jansen (602_CR37) 2015; 313 Alzheimer’s Association (602_CR2) 2016; 12 G Martínez (602_CR9) 2017; 11 602_CR22 AI Ramirez (602_CR50) 2017; 9 R Blesa (602_CR28) 2001; 39 S Hagen (602_CR41) 2011; 31 AA Sadun (602_CR17) 1990; 97 602_CR29 A Tas (602_CR19) 2015; 93 602_CR24 GJ Jaffe (602_CR12) 2004; 137 JC Morris (602_CR30) 1993; 43 Q Yang (602_CR34) 2010; 18 MS Byerly (602_CR15) 2009; 1 P Lozoya-Delgado (602_CR27) 2012; 54 M Boada (602_CR21) 2014; 10 M Alegret (602_CR23) 2012; 34 602_CR32 602_CR31 N Pakrou (602_CR33) 2008; 17 BT Hyman (602_CR8) 2012; 8 RA Sperling (602_CR3) 2011; 3 D Sánchez (602_CR43) 2018; 8 O Rodriguez-Gomez (602_CR20) 2017; 4 R Ossenkoppele (602_CR36) 2015; 313 BE O’Bryhim (602_CR45) 2018; 136 RE Amariglio (602_CR26) 2012; 34 SE Counts (602_CR11) 2017; 14 |
References_xml | – volume: 8 start-page: 16345 issue: 1 year: 2018 ident: 602_CR43 publication-title: Sci Rep doi: 10.1038/s41598-018-34577-3 – ident: 602_CR46 doi: 10.1111/aos.14121 – volume: 17 start-page: 43 issue: 1 year: 2008 ident: 602_CR33 publication-title: J Glaucoma doi: 10.1097/IJG.0b013e318133fb32 – volume: 78 start-page: 387 issue: 6 year: 2012 ident: 602_CR39 publication-title: Neurology. doi: 10.1212/WNL.0b013e318245d295 – volume: 12 start-page: 459 issue: 4 year: 2016 ident: 602_CR2 publication-title: Alzheimers Dement doi: 10.1016/j.jalz.2016.03.001 – ident: 602_CR10 doi: 10.1371/journal.pone.0116802 – volume: 9 start-page: 214 year: 2017 ident: 602_CR50 publication-title: Front Aging Neurosci doi: 10.3389/fnagi.2017.00214 – volume: 137 start-page: 156 issue: 1 year: 2004 ident: 602_CR12 publication-title: Am J Ophthalmol doi: 10.1016/S0002-9394(03)00792-X – ident: 602_CR51 – volume: 10 start-page: 844 issue: 6 year: 2014 ident: 602_CR4 publication-title: Alzheimers Dement doi: 10.1016/j.jalz.2014.01.001 – volume: 11 start-page: CD012883 year: 2017 ident: 602_CR9 publication-title: Cochrane Database Syst Rev – volume: 14 start-page: 35 issue: 1 year: 2017 ident: 602_CR11 publication-title: Neurotherapeutics. doi: 10.1007/s13311-016-0481-z – ident: 602_CR22 doi: 10.3233/JAD-160915 – volume: 1 start-page: 380 issue: 3 year: 2009 ident: 602_CR15 publication-title: Wiley Interdiscip Rev Syst Biol Med doi: 10.1002/wsbm.22 – ident: 602_CR47 doi: 10.1016/j.dadm.2016.09.001 – volume: 97 start-page: 9 issue: 1 year: 1990 ident: 602_CR17 publication-title: Ophthalmology. doi: 10.1016/S0161-6420(90)32621-0 – ident: 602_CR40 doi: 10.1016/j.jalz.2018.10.003 – volume: 60 start-page: 201 issue: 1 year: 2015 ident: 602_CR6 publication-title: Arch Gerontol Geriatr doi: 10.1016/j.archger.2014.10.015 – volume: 313 start-page: 1924 issue: 19 year: 2015 ident: 602_CR37 publication-title: JAMA. doi: 10.1001/jama.2015.4668 – volume: 136 start-page: 1242 issue: 11 year: 2018 ident: 602_CR45 publication-title: JAMA Ophthalmol doi: 10.1001/jamaophthalmol.2018.3556 – volume: 83 start-page: 1359 issue: 15 year: 2014 ident: 602_CR7 publication-title: Neurology. doi: 10.1212/WNL.0000000000000856 – ident: 602_CR24 doi: 10.1371/journal.pone.0076436 – volume: 93 start-page: e507 issue: 6 year: 2015 ident: 602_CR19 publication-title: Acta Ophthalmol doi: 10.1111/aos.12614 – volume: 23 start-page: 1807 issue: 8 year: 2018 ident: 602_CR35 publication-title: Mol Psychiatry doi: 10.1038/mp.2017.146 – ident: 602_CR31 – volume: 18 start-page: 21293 issue: 20 year: 2010 ident: 602_CR34 publication-title: Opt Express doi: 10.1364/OE.18.021293 – ident: 602_CR29 doi: 10.1016/0022-3956(75)90026-6 – volume: 34 start-page: 580 issue: 6 year: 2012 ident: 602_CR26 publication-title: J Clin Exp Neuropsychol doi: 10.1080/13803395.2012.666230 – volume: 8 start-page: 1 issue: 1 year: 2012 ident: 602_CR8 publication-title: Alzheimers Dement doi: 10.1016/j.jalz.2011.10.007 – volume: 10 start-page: 409 issue: 3 year: 2014 ident: 602_CR21 publication-title: Alzheimers Dement doi: 10.1016/j.jalz.2013.03.006 – volume: 4 start-page: 100 issue: 2 year: 2017 ident: 602_CR20 publication-title: J Prev Alzheimer’s Dis – volume: 13 start-page: 997 issue: 10 year: 2014 ident: 602_CR38 publication-title: Lancet Neurol doi: 10.1016/S1474-4422(14)70194-2 – volume: 7 start-page: 263 issue: 3 year: 2011 ident: 602_CR1 publication-title: Alzheimers Dement doi: 10.1016/j.jalz.2011.03.005 – volume: 31 start-page: 41 issue: 1 year: 2011 ident: 602_CR41 publication-title: Retina. doi: 10.1097/IAE.0b013e3181dde71e – volume: 313 start-page: 1939 issue: 19 year: 2015 ident: 602_CR36 publication-title: JAMA. doi: 10.1001/jama.2015.4669 – volume: 48 start-page: 1109 issue: 4 year: 2015 ident: 602_CR25 publication-title: J Alzheimers Dis doi: 10.3233/JAD-150594 – volume: 6 start-page: 162 year: 2017 ident: 602_CR13 publication-title: Alzheimer’s Dement Diagn Assess Dis Monit. – volume: 39 start-page: 1150 issue: 11 year: 2001 ident: 602_CR28 publication-title: Neuropsychologia. doi: 10.1016/S0028-3932(01)00055-0 – volume: 6 start-page: 11 issue: 1 year: 2010 ident: 602_CR5 publication-title: Alzheimers Dement doi: 10.1016/j.jalz.2009.10.002 – ident: 602_CR48 doi: 10.1007/s00415-014-7374-z – volume: 54 start-page: 137 issue: 3 year: 2012 ident: 602_CR27 publication-title: Rev Neurol – volume: 54 start-page: S204 issue: Suppl 1 year: 2011 ident: 602_CR18 publication-title: Neuroimage doi: 10.1016/j.neuroimage.2010.06.020 – volume: 3 start-page: 111cm33 issue: 111 year: 2011 ident: 602_CR3 publication-title: Sci Transl Med doi: 10.1126/scitranslmed.3002609 – volume: 10 start-page: 196 year: 2018 ident: 602_CR49 publication-title: Alzheimers Dement – volume: 43 start-page: 2412 issue: 11 year: 1993 ident: 602_CR30 publication-title: Neurology. doi: 10.1212/WNL.43.11.2412-a – volume: 34 start-page: 209 issue: 2 year: 2012 ident: 602_CR23 publication-title: J Clin Exp Neuropsychol doi: 10.1080/13803395.2011.630652 – volume: 9 start-page: 8698 issue: 1 year: 2019 ident: 602_CR42 publication-title: Sci Rep doi: 10.1038/s41598-019-45055-9 – ident: 602_CR32 doi: 10.1038/eye.2015.94 – ident: 602_CR44 doi: 10.1186/s13195-017-0239-9 – volume: 139 start-page: 123 year: 2017 ident: 602_CR14 publication-title: Vis Res doi: 10.1016/j.visres.2017.05.009 – volume: 6 start-page: E105 issue: 4 year: 2009 ident: 602_CR16 publication-title: Rev Neurol Dis |
SSID | ssj0066284 |
Score | 2.3697033 |
Snippet | Background
Optical coherence tomography (OCT) of the retina is a fast and easily accessible tool for the quantification of retinal structural measurements.... Optical coherence tomography (OCT) of the retina is a fast and easily accessible tool for the quantification of retinal structural measurements. Multiple... Background Optical coherence tomography (OCT) of the retina is a fast and easily accessible tool for the quantification of retinal structural measurements.... Abstract Background Optical coherence tomography (OCT) of the retina is a fast and easily accessible tool for the quantification of retinal structural... |
SourceID | doaj pubmedcentral proquest pubmed crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 37 |
SubjectTerms | Alzheimer's disease Biomarkers Biomedical and Life Sciences Biomedicine Brain research Clinical trials Cognitive ability Dementia Diabetes Diabetic retinopathy Disease Florbetaben Geriatric Psychiatry Geriatrics/Gerontology Glaucoma Memory Neurology Neurosciences Optic nerve Optical coherence tomography Optics Pathology Positron emission tomography Retina Retinal thickness Software Subject Cognitive Decline Subjective cognitive decline β-Amyloid |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELZQT1wQiL9AQUbiBlGd2LFjbm3VVUGCU5F6s_wrFmhasbsH3oZngEfgzjMxYyehy-8FKadkbFkz4_FMPN8MIY-T7r0DP6N2QspaONfW1rYSdVnbmJJkDgHOL1_J49fixWl3eqnVF-aElfLAhXF7ygc4BR1EUiyJ0PY2JMmF65xNse9SROvLNJuCqWKDpQSrO0Fkerm3aniTkciIopZgA_TWMZSr9f_Oxfw1U_Kn69J8Ci2uk2uj-0j3y7JvkCtxuEk-XeIxHROvKKITkRTz2d-hPaN2CPTb59qeQYy-DNRhcwhqvd-cjS286BKfCaC1oviPlq427m0xinRONaIhIqIyPqMLBJL45dcvdP_wiBZM00d6kKd-jsS5rvgtcrI4Ojk8rsfOC7UHD24NFlCAW5Bs1yuRpLCtDjJ13rEYpffCh6h73SSlndMBDjTutGB4oRc5lj7mt8nOcD7Eu4QqHgXzVqXWcWE9sxCiwLTcpZi60KWKNJMcjB-rkmNzjPcmRye9NEV2BmRnsuyMrsiTecxFqcnxV-oDFO9MifW08wvQMjNqmfmXllVkd1IOM27ylWk58Ek1WjQVeTR_hu2Jdy52iOcbpOk71QoI2ypyp-jSvBKwpRzYxiqitrRsa6nbX4blm1wCXGHYzmHk00kffyzrz6y49z9YcZ9cbfNGQlzmLtlZf9jEB-CYrd3DvAe_A0aaOkw priority: 102 providerName: Directory of Open Access Journals – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagXLigIl6BgozEDSKS-BX31q66KkhwKlJvlp9igaaI3T303_Q3lJ_Avb-JGedBFwoSUk7J2LI8D8_E880Q8iLp1jvwM0rHpSy5c01pbSNRlrWNKcnKIcD53Xt5-IG_PRbHQ5kcxMJcvb-vW_l6WbM6Y4gR_yxBe_VNckuA4UVpnsnZaHWlBDs7gmKuHbdx8OT6_Nc5lX_mRv52QZrPnfk2uTM4jHSv5_BdciN298j5lV2lQ6oVRTwikmIG-2e0YNR2gV5elPYEovJFoA7bQVDr_fpkaNpFF_iMkKwlxb-ydLl2n3ozSKfkIhoiYijjLp0jdMQvfnyne7MD2qOYzuh-nvoNEudK4vfJ0fzgaHZYDr0WSg8-2wpsHgdHIFnRKp4kt40OMgnvqhil99yHqFtdJ6Wd0wGOMOY0r_AKLzIsdswekK3utIuPCFUs8spblRrHuPWVBV7BtMylmEQQqSD1yAfjhzrk2A7ji8nxSCtNzzsDvDOZd0YX5OU05mtfheOf1PvI3okSK2jnFyBYZlBIo3wA78pBhF4lHprWhiQZd8LZFFuRYkF2RuEwg1ovTcNgn1SteV2Q59NnUEi8ZbFdPF0jTStUwyFQK8jDXpamlYD1ZLBtVUHUhpRtLHXzS7f4mIt-KwzUGYx8Ncrjr2X9fSse_x_5E3K7ySqDmMsdsrX6to5PwelauWdZ234CF0EpWw priority: 102 providerName: Springer Nature |
Title | Association between retinal thickness and β-amyloid brain accumulation in individuals with subjective cognitive decline: Fundació ACE Healthy Brain Initiative |
URI | https://link.springer.com/article/10.1186/s13195-020-00602-9 https://www.ncbi.nlm.nih.gov/pubmed/32234080 https://www.proquest.com/docview/2391471941 https://www.proquest.com/docview/2385724597 https://pubmed.ncbi.nlm.nih.gov/PMC7110730 https://doaj.org/article/7cd071b3380f4d28adf634b5bafe85fe |
Volume | 12 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagvXBBIF6BsjISN4iaxI4Tc0Hd1a4KEhVCRdqb5Scs0Gzb3T303_Ab4Cdw5zcx4zzK8qiUyyaTyOt5eMaeb4aQp0HW1oCfkRouRMqNKVKtC4GyLLUPQWQGAc5vjsThe_56Xs67DbdVl1bZ28RoqN3S4h75fsFkDoZU8vzl6VmKXaPwdLVroXGd7ObgiWDrhmo-BFxCgO3tgTK12F_lLI94ZMRSC7AEcmsxijX7_-Vo_p0v-cehaVyLZrfIzc6JpAct12-Ta765Q77-NtO0S7-iiFFEUsxq_4xWjerG0Z_fUn0CkfrCUYMtIqi2dnPSNfKiC7x6mNaK4k4tXW3Mp9Y00iHhiDqPuEr_gs4QTmIXP77Tg8mUtsimCzqOn36FxLG6-F1yPJseTw7Trv9CasGPW4Md5OAcBF3WFQ-C60I6EUprMu-Ftdw6L2uZh0oaIx0sa8xInuGxnmdYAJndIzvNsvEPCK2Y55nVVSgM49pmGgIV-CwzwYfSlSEhec8HZbva5Ngi44uKMUotVMs7BbxTkXdKJuTZ8M5pW5njSuoxsnegxKra8cby_IPqlFRV1oHHZSBqzwJ3Ra1dEIyb0ujg6zL4hOz1wqE6VV-pS8FMyJPhMSgpnrzoxi83SFOXVcEheEvI_VaWhpGARWUwbVlCqi0p2xrq9pNm8TEWAq8weGfw5vNeHi-H9f-peHj1v3hEbhRRRRB3uUd21ucb_xgcr7UZRe0akd3x9OjtO_g1EZNR3MT4BfR5M_Y |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxELZKeoALAvFaKGAkOMGqu2uvd41UoaYkSmgbIRSk3iw_IdBuStMI5d_wG-DMiTu_CY93NyU8equUU3bW8nrGn8f2fDMIPXa81Mr7GbGijMVUqSyWMmNgy1xa51iigOC8P2KDt_TVQX6whr63XBgIq2wxMQC1mWo4I9_MCE89kHKavjj-FEPVKLhdbUtoyKa0gtkKKcYaYseuXXz2W7jZ1vCl1_eTLOv3xjuDuKkyEGvvrZz62U79EuhkXhbUMSozbpjLtUqsZVpTbSwveeoKrhQ3HryJ4jSByytLIM0v8c1eQusUzk86aL3bG71-0y4FjHnwb5k6JducpSQNhGggczMPRXxlNQxFA_7l6f4dsPnHrW1YDPvX0NXGi8XbtdldR2u2uoG-_KZq3MR_YSBJgiiE1X8EWMWyMvjn11geLQ6nE4MV1KjAfmTnR00lMTyBX8sTm2E4KsazufpQYzNeRjxhY4HYaZ_jPvBZ9OTHN7y908M1tWqBu6HpIQiH9OY30fgiVHMLdappZe8gXBBLEy0LlylCpU6k3yn5Zoly1uUmdxFKWz0I3SRHhxodhyJskkomat0JrzsRdCd4hJ4u3zmuU4OcK90F9S4lIa13-GN68k40KCEKbbzLpwgpE0dNVkrjGKEqV9LZMnc2QhutcYgGa2bibGZE6NHysUcJuPqRlZ3OQabMi4z63WOEbte2tOyJh3Tihy2JULFiZStdXX1STd6HTOQFnB4Q_-az1h7PuvX_obh7_lc8RJcH4_09sTcc7d5DV7IwXYAEuoE6pydze997gafqQTPXMBIXPLt_ARfYcnQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagSIgLAvEKFDASN4iaxI4dc2uXrloeFYci9Wb5CQs0W3V3D_wbfgP8BO78JmacB10oSEh72owjy_PwTDzfZ0IeR9U4C3lGbrkQObe2yo2pBNqyMiFGUVgEOL8-EHtv-Yuj-ugMij91uw9Hkh2mAVma2uXWiY-dizdia1GyMiGLERUtwKfVRXIJubqwqW8iJkMsFgKi7wCVOXfc2naUWPvPSzX_7Jj87dg07UbTa-Rqn0bS7U7v18mF0N4gX86sNe0bsCiiFFEU-9o_YlyjpvX0x9fcHEOtPvPU4iUR1Di3Ou6v8qIz_A1ArQXFb7V0sbIfuuBIx5Yj6gMiK8MzOkVAiZt9_0a3J7u0wzZ9pjvp1fsonPjFb5LD6e7hZC_vb2DIHWRyS4iEHNKDaOpG8ii4qZQXsXa2CEE4x50PqlFllMpa5WFjY1aBFiAMBIYUyOwW2WjnbbhDqGSBF87IWFnGjSsMlCrwWmZjiLWvY0bKQQ_a9ezkeEnGJ52qlEboTncadKeT7rTKyJNxzEnHzfFP6R1U7yiJvNrpj_npO927qZbOQ85loW4vIvdVY3wUjNvamhiaOoaMbA7GoXtnX-iKwTrJUvEyI4_Gx-CmePZi2jBfoUxTy4pD-ZaR250tjTOBmMpg2YqMyDUrW5vq-pN29j5RgUss3xmMfDrY469p_X0p7v6f-ENy-c3zqX61f_DyHrlSJe9BUOYm2ViersJ9yMqW9kFyvJ-LSDSa |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+between+retinal+thickness+and+%CE%B2-amyloid+brain+accumulation+in+individuals+with+subjective+cognitive+decline%3A+Fundaci%C3%B3+ACE+Healthy+Brain+Initiative&rft.jtitle=Alzheimer%27s+research+%26+therapy&rft.au=Marqui%C3%A9%2C+Marta&rft.au=Valero%2C+Sergi&rft.au=Castilla-Marti%2C+Miguel&rft.au=Mart%C3%ADnez%2C+Joan&rft.date=2020-03-31&rft.issn=1758-9193&rft.eissn=1758-9193&rft.volume=12&rft.issue=1&rft.spage=37&rft_id=info:doi/10.1186%2Fs13195-020-00602-9&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1758-9193&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1758-9193&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1758-9193&client=summon |